Clinical trial
Evolut™ EXPAND TAVR II Pivotal Trial
NCT05149755 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evolut™ EXPAND TAVR II Pivotal Trial
- Lead sponsor
- Medtronic Cardiovascular
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 27, 2022
- Completion date
- December 31, 2034
- Enrollment
- 650 (estimated)
- Sites
- 94
Conditions
As the registry lists them; a condition with its own page is linked.
moderate aortic valve stenosis